Columnist Teri Sforza writes that childhood obesity in California is on the rise, state data shows. Free school meals have ...

A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name ...

Novo Nordisk’s blockbuster GLP-1 diabetes drug Ozempic led to improvements in some measures of alcohol use disorder in a ...

Ozempic made headlines after a study came out linking this and similar medications like Wegovy to an eye condition that can cause irreversible damage and permanent vision loss, including total ...

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don't just curb their desire to eat; for some, they also lead them to drink ...

Amy Schumer is getting candid about her unpleasant experience on the weight loss drug Ozempic. The comedian and actress, 43, ...

Plastic surgeons are seeing more patients opting for breast reductions and dissolving facial fillers. They reveal that patients want a more natural, athletic and effortless look.

Since the early 2000s, weight loss trends have come and gone. However, Ozempic, the popular injectable diabetes medication gaining fame as a weight loss wonder drug, doesn’t seem to be going anywhere.

Novo Nordisk’s Ozempic ... T2D, before being granted expanded approval in 2020 to reduce the risk of major cardiovascular events in adults with T2D and known heart disease. The FDA’s latest decision ...

Ozempic, the blockbuster GLP-1 drug that was ... The clinical study was stopped early after reaching positive endpoints sooner than expected, and no new safety risks were identified in this ...

Semaglutide is the active ingredient in diabetes drug Ozempic and obesity medication Wegovy (since Wegovy was approved in 2021, Ozempic has become a common off-label treatment for obesity).